NM_000540.2(RYR1):c.8616+7G>A AND Malignant hyperthermia, susceptibility to, 1

Clinical significance:Likely benign (Last evaluated: Jun 17, 2019)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:
current
Accession:
RCV000307508.2

Allele description [Variation Report for NM_000540.2(RYR1):c.8616+7G>A]

NM_000540.2(RYR1):c.8616+7G>A

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.2(RYR1):c.8616+7G>A
HGVS:
  • NC_000019.10:g.38506384G>A
  • NG_008866.1:g.77685G>A
  • NM_000540.2:c.8616+7G>A
  • NM_001042723.2:c.8616+7G>A
  • LRG_766t1:c.8616+7G>A
  • LRG_766:g.77685G>A
  • NC_000019.9:g.38997024G>A
Links:
dbSNP: rs200023171
NCBI 1000 Genomes Browser:
rs200023171
Molecular consequence:
  • NM_000540.2:c.8616+7G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001042723.2:c.8616+7G>A - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Malignant hyperthermia, susceptibility to, 1 (MHS1)
Synonyms:
Anesthesia related hyperthermia; Malignant hyperpyrexia; Fulminating hyperpyrexia; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007783; MedGen: C2930980; Orphanet: 423; OMIM: 145600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000412590Illumina Clinical Services Laboratory,Illuminacriteria provided, single submitter
Likely benign
(Jun 17, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Functional characterization of ryanodine receptor (RYR1) sequence variants using a metabolic assay in immortalized B-lymphocytes.

Zullo A, Klingler W, De Sarno C, Ferrara M, Fortunato G, Perrotta G, Gravino E, Di Noto R, Lehmann-Horn F, Melzer W, Salvatore F, Carsana A.

Hum Mutat. 2009 Apr;30(4):E575-90. doi: 10.1002/humu.20991.

PubMed [citation]
PMID:
19191333

Details of each submission

From Illumina Clinical Services Laboratory,Illumina, SCV000412590.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 25, 2021

Support Center